PAS
REGN icon

Park Avenue Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Park Avenue Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$975K Sell
1,563
-112
-7% -$76.2K 0.01% 967
2026
Q1 		$1.29M Buy
1,675
+59
+4% +$45.2K 0.01% 706
2025
Q4 		$1.25M Buy
1,616
+49
+3% +$33.3K 0.01% 708
2025
Q3 		$881K Buy
1,567
+98
+7% +$55.4K 0.01% 929
2025
Q2 		$771K Sell
1,469
-11
-0.7% -$6.14K 0.01% 870
2025
Q1 		$938K Sell
1,480
-539
-27% -$371K 0.01% 645
2024
Q4 		$1.44M Buy
2,019
+130
+7% +$109K 0.01% 598
2024
Q3 		$1.99M Buy
1,889
+134
+8% +$149K 0.02% 436
2024
Q2 		$1.84M Buy
1,755
+84
+5% +$81.4K 0.02% 438
2024
Q1 		$1.61M Buy
1,671
+141
+9% +$134K 0.02% 481
2023
Q4 		$1.34M Buy
1,530
+101
+7% +$83.2K 0.02% 499
2023
Q3 		$1.18M Buy
+1,429
New +$1.12M 0.02% 496
2023
Q1 		– Sell
-1,111
Closed -$802K – 1063
2022
Q4 		$802K Buy
1,111
+64
+6% +$47.2K 0.01% 614
2022
Q3 		$721K Buy
1,047
+65
+7% +$40.9K 0.01% 591
2022
Q2 		$580K Buy
982
+122
+14% +$79.3K 0.01% 663
2022
Q1 		$601K Sell
860
-777
-47% -$492K 0.01% 669
2021
Q4 		$1.03M Buy
1,637
+948
+138% +$583K 0.02% 457
2021
Q3 		$417K Sell
689
-244
-26% -$151K 0.01% 717
2021
Q2 		$521K Sell
933
-173
-16% -$87.6K 0.01% 614
2021
Q1 		$523K Buy
1,106
+415
+60% +$202K 0.01% 570
2020
Q4 		$334K Buy
691
+305
+79% +$165K 0.01% 642
2020
Q3 		$216K Buy
+386
New +$234K 0.01% 689

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Park Avenue Securities's REGN Position: Q2 2026 in Review

Park Avenue Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 6.7% in Q2 2026, selling an estimated $76.2K and leaving 1,563 shares worth $975K. The position accounts for 0.01% of the portfolio, ranked #967.

Park Avenue Securities first reported a position in REGN in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.99M in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Park Avenue Securities held 1,563 shares of Regeneron Pharmaceuticals worth $975K as of Q2 2026.
  • Park Avenue Securities sold 112 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Regeneron Pharmaceuticals made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #967 holding.
  • Park Avenue Securities first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 22 quarters since.
  • Park Avenue Securities's Regeneron Pharmaceuticals position peaked at $1.99M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.